August 27, 2016 3:58 AM ET

Biotechnology

Company Overview of Syndax Pharmaceuticals, Inc.

Executive Profile

Richard A. Heyman Ph.D.

AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 11 different industries.

See Board Relationships
59--

Background

Dr. Richard A. Heyman, also known as Rich, Ph.D., serves as an Executive Chairman and Co-Founder of Metacrine Inc. Dr. Heyman serves as Life Science Advisor at Ventana Capital Management, LLC. He served as an Interim Chief Executive Officer at ORIC Pharmaceuticals Inc. until August 10, 2016. Dr. Heyman served as the Chief Executive Officer and President at Seragon Pharmaceuticals Inc., which he co-founded in 2013 and sold to Genentech (Roche) in 2014. He co-founded Aragon ...

Corporate Headquarters

400 Totten Pond Road
Waltham, Massachusetts 02451

United States

Phone: 781-419-1400
Fax: 781-419-1420

Board Members Memberships

Director
Director

Education

PhD
University of Minnesota
BS
University of Connecticut

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Syndax Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.